Correlation Between Ibio and Acasti Pharma
Can any of the company-specific risk be diversified away by investing in both Ibio and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ibio and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ibio Inc and Acasti Pharma, you can compare the effects of market volatilities on Ibio and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ibio with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ibio and Acasti Pharma.
Diversification Opportunities for Ibio and Acasti Pharma
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ibio and Acasti is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Ibio Inc and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Ibio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ibio Inc are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Ibio i.e., Ibio and Acasti Pharma go up and down completely randomly.
Pair Corralation between Ibio and Acasti Pharma
Given the investment horizon of 90 days Ibio Inc is expected to generate 2.61 times more return on investment than Acasti Pharma. However, Ibio is 2.61 times more volatile than Acasti Pharma. It trades about 0.02 of its potential returns per unit of risk. Acasti Pharma is currently generating about 0.04 per unit of risk. If you would invest 1,240 in Ibio Inc on August 29, 2024 and sell it today you would lose (977.00) from holding Ibio Inc or give up 78.79% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.56% |
Values | Daily Returns |
Ibio Inc vs. Acasti Pharma
Performance |
Timeline |
Ibio Inc |
Acasti Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
Ibio and Acasti Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ibio and Acasti Pharma
The main advantage of trading using opposite Ibio and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ibio position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.Ibio vs. Jaguar Animal Health | Ibio vs. GeoVax Labs | Ibio vs. Ocugen Inc | Ibio vs. Tonix Pharmaceuticals Holding |
Acasti Pharma vs. Tonix Pharmaceuticals Holding | Acasti Pharma vs. Jaguar Animal Health | Acasti Pharma vs. Ibio Inc | Acasti Pharma vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |